- Home
- ZTO vs BDTX Comparison
ZTO vs BDTX Comparison
Compare ZTO & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTO
- BDTX
- Stock Information
- Founded
- ZTO 2002
- BDTX 2014
- Country
- ZTO China
- BDTX United States
- Employees
- ZTO N/A
- BDTX N/A
- Industry
- ZTO Advertising
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZTO Consumer Discretionary
- BDTX Health Care
- Exchange
- ZTO Nasdaq
- BDTX Nasdaq
- Market Cap
- ZTO 14.9B
- BDTX 181.4M
- IPO Year
- ZTO 2016
- BDTX 2020
- Fundamental
- Price
- ZTO $19.01
- BDTX $4.09
- Analyst Decision
- ZTO Strong Buy
- BDTX Strong Buy
- Analyst Count
- ZTO 4
- BDTX 5
- Target Price
- ZTO $21.90
- BDTX $12.00
- AVG Volume (30 Days)
- ZTO 1.8M
- BDTX 1.1M
- Earning Date
- ZTO 11-18-2025
- BDTX 11-04-2025
- Dividend Yield
- ZTO 3.17%
- BDTX N/A
- EPS Growth
- ZTO N/A
- BDTX N/A
- EPS
- ZTO 1.13
- BDTX 0.25
- Revenue
- ZTO $6,465,566,040.00
- BDTX $70,000,000.00
- Revenue This Year
- ZTO $11.48
- BDTX N/A
- Revenue Next Year
- ZTO $12.42
- BDTX N/A
- P/E Ratio
- ZTO $16.52
- BDTX $16.54
- Revenue Growth
- ZTO 14.70
- BDTX N/A
- 52 Week Low
- ZTO $16.34
- BDTX $1.20
- 52 Week High
- ZTO $25.70
- BDTX $4.38
- Technical
- Relative Strength Index (RSI)
- ZTO 50.66
- BDTX 61.68
- Support Level
- ZTO $18.11
- BDTX $3.69
- Resistance Level
- ZTO $19.54
- BDTX $4.38
- Average True Range (ATR)
- ZTO 0.42
- BDTX 0.26
- MACD
- ZTO -0.01
- BDTX 0.00
- Stochastic Oscillator
- ZTO 48.91
- BDTX 66.35
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.